Trademark Overview
On Thursday, May 8, 2025, a trademark application was filed for GARZULYS with the United States Patent and Trademark Office. The USPTO has given the GARZULYS trademark a serial number of 99176330. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, May 8, 2025. This trademark is owned by Hong Kong King-Friend, Industrial Company, Ltd.. The GARZULYS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin aspart; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin aspart; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin aspart; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics